1. MHC class II molecules on pancreatic cancer cells indicate a potential for neo-antigen-based immunotherapy. (31st December 2022) Authors: Baleeiro, Renato B.; Bouwens, Christian J.; Liu, Peng; Di Gioia, Carmela; Dunmall, Louisa S. Chard; Nagano, Ai; Gangeswaran, Rathistevy; Chelala, Claude; Kocher, Hemant M.; Lemoine, Nicholas R.; Wang, Yaohe Journal: Oncoimmunology Issue: Volume 11:Number 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗